Idiopathic hyperammonemic encephalopathy secondary to gemcitabine–cisplatin treatment
Crossref DOI link: https://doi.org/10.1007/s00280-022-04476-6
Published Online: 2022-09-20
Published Print: 2022-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Verkerk, Karlijn http://orcid.org/0000-0002-5882-4980
Otten, Hans-Martin
Huitema, Alwin D. R.
Text and Data Mining valid from 2022-09-20
Version of Record valid from 2022-09-20
Article History
Received: 12 June 2022
Accepted: 13 September 2022
First Online: 20 September 2022
Declarations
:
: The authors have declared no conflicts of interest.